NFYC2: A Potential Drug Target Or Biomarker (G494127)
NFYC2: A Potential Drug Target Or Biomarker
The NFYC pseudogene 2 (NFYC2) is a gene that has been identified as a potential drug target or biomarker for the treatment of various diseases, including cancer. The NFYC family of genes plays a role in the development and maintenance of normal tissues, and research has suggested thatNFYC2 may be involved in a variety of physiological processes.
One of the key features ofNFYC2 is its role in cell signaling. NFYC2 has been shown to play a role in the regulation of cell growth, differentiation, and survival. It has been shown to interact with a variety of signaling pathways, including the TGF-β pathway and the Wnt pathway.
In addition to its role in cell signaling, NFYC2 has also been shown to be involved in the regulation of cellular processes that are important for tissue development and homeostasis. For example, research has suggested that NFYC2 may be involved in the development of tissues that are important for the development of organs, such as the liver and the pancreas.
Due to its involvement in these processes, NFYC2 has been identified as a potential drug target or biomarker for a variety of diseases. For example, research has suggested thatNFYC2 may be a potential target for the treatment of cancer, as it has been shown to play a role in the regulation of cellular processes that are important for tumor growth and progression.
In addition to its potential as a drug target or biomarker, NFYC2 has also been shown to have potential as a diagnostic tool. For example, research has suggested that NFYC2 may be expressed in a variety of tissues and cells, and that it may be a useful biomarker for the diagnosis of certain diseases.
Overall, the NFYC pseudogene 2 is a promising candidate for as a drug target or biomarker. Further research is needed to fully understand its role in these processes and to determine its potential as a therapeutic intervention.
Protein Name: NFYC Pseudogene 2
More Common Targets
NGB | NGDN | NGEF | NGF | NGFR | NGFR-AS1 | NGLY1 | NGRN | NHEG1 | NHEJ1 | NHERF1 | NHERF2 | NHERF4 | NHLH1 | NHLH2 | NHLRC1 | NHLRC2 | NHLRC3 | NHLRC4 | NHP2 | NHP2P1 | NHS | NHSL1 | NHSL1-AS1 | NHSL2 | NIBAN1 | NIBAN2 | NIBAN3 | Nicalin-NOMO complex | NICN1 | Nicotinic (alpha4beta2)2alpha4 receptor | Nicotinic (alpha4beta2)2beta2 receptor | Nicotinic alpha1beta1deltaepsilon Receptor | Nicotinic alpha1beta1deltagamma Receptor | Nicotinic alpha3alpha6beta2 Receptor | Nicotinic alpha3beta2 receptor | Nicotinic alpha3beta2beta3 receptor | Nicotinic alpha3beta4 Receptor | Nicotinic alpha4beta2 receptor | Nicotinic alpha4beta2alpha5 Receptor | Nicotinic alpha4beta4 receptor | Nicotinic alpha6alpha3beta2 Receptor | Nicotinic alpha6alpha3beta2beta3 receptor | Nicotinic alpha6beta2alpha4beta2beta3 receptor | Nicotinic alpha6beta2beta3 receptor | Nicotinic alpha6beta4beta3alpha5 receptor | Nicotinic alpha9alpha10 Receptor | NID1 | NID2 | NIF3L1 | NIFK | NIFK-AS1 | NIHCOLE | NIM1K | NIN | NINJ1 | NINJ2 | NINJ2-AS1 | NINL | NIP7 | NIPA1 | NIPA2 | NIPAL1 | NIPAL2 | NIPAL3 | NIPAL4 | NIPBL | NIPBL-DT | NIPSNAP1 | NIPSNAP2 | NIPSNAP3A | NIPSNAP3B | NISCH | NIT1 | NIT2 | Nitric oxide synthase (NOS) | NKAIN1 | NKAIN1P1 | NKAIN2 | NKAIN3 | NKAIN4 | NKAP | NKAPD1 | NKAPL | NKAPP1 | NKD1 | NKD2 | NKG7 | NKILA | NKIRAS1 | NKIRAS2 | NKPD1 | NKRF | NKTR | NKX1-1 | NKX1-2 | NKX2-1 | NKX2-1-AS1 | NKX2-2 | NKX2-3